Egfr Tyrosine Kinase Inhibitor
1 clinical trials · Condition
◉ Watch Egfr Tyrosine Kinase Inhibitor
| Record | Firm | Date |
|---|---|---|
| Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer (NCT07267247) | Taichung Veterans General Hospital | 2022-06-01 |
Track Egfr Tyrosine Kinase Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.